The U.S. Preventive Services Task Force recommends against PSA (prostate specific antigen) screening for prostate cancer. The task force currently gives PSA screening a grade D, meaning that there is moderate or high certainty that the PSA test has no benefit or that the harms outweigh the benefits. This recommendation was first issued in 2011.
Read MoreJune is Men's Health Month and in light of Father's Day, we thought it'd be interesting to put together the top 5 men's health findings from 2015 so far. Here's what you need to know.
Read MoreWith Father’s Day coming up this Sunday, many wives, children, and families will be searching the perfect gift to give a father that shows them how much they appreciate them. The best gift you can give a person is their health and well-being.
Read MoreControversy remains surrounding the use of the PSA test to screen for prostate cancer. This is due to the belief that the PSA test may lead to over-diagnosis and over-treatment in men with low-grade, less aggressive forms of the disease. Clinicians have been long awaiting a new approach to screen for prostate cancer because the current PSA test is simply not accurate enough.
Read MoreJohnathan Watkins of King's College London published the first ever study analyzing the health effects of unemployment related to prostate cancer in the journal, eCancerMedicalScience — an open access journal from the European Institute of Oncology.
Read More
